Polydex Pharmaceuticals Ltd. (PC) Stock Price - POLXF

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Polydex Pharmaceuticals Ltd. (PC) POLXF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 1.3 - - - 1.3 08:11:00
Bid Price Ask Price Spread Spread % News
1.23 1.31 0.08 6.11% - -
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Polydex Pharmaceuticals Ltd. (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.42M 3.4M $ -1.59M - -2.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Polydex Pharmaceuticals Ltd. (PC) News

Real-Time news about Polydex Pharmaceuticals Ltd. (PC) (Other OTC): 0 recent articles

Latest POLXF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical POLXF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week1.281.311.2551.30002k4k3k0.021.56%
1 Month1.281.311.221.2889714k1k0.021.56%
3 Months1.31.311.091.247738k2k0-
6 Months1.06221.310.971.1559323k3k0.237822.39%
1 Year1.281.5050.871.2186226k3k0.021.56%
3 Years0.75052.820.711.4158179k4k0.549573.22%
5 Years0.222.820.151.10101107k5k1.08490.91%

Polydex Pharmaceuticals Ltd. (PC) Description

Polydex Pharmaceuticals Limited (the "Company") is engaged in the research, development, manufacture and marketing of biotechnology-based products for the veterinary and human pharmaceutical markets. This includes the manufacture of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry. The Company focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The name Polydex combines the words "polymer" and "dextran." The Company conducts its business operations through its two wholly-owned subsidiaries/divisions. The manufacture and sale of Dextran and derivative products is conducted through Dextran Products, incorporated in Canada in 1966 (Dextran Products),and Chemdex Inc (Chemdex) which is incorporated in the state of Kansas, United States.FOR ADDITIONAL FINANCIAL INFORMATION AND NEWS, INCLUDING MORE RECENT QUARTERLY REPORTING, PLEASE VISIT OUR WEBSITE!
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180319 12:36:45